Demonstrates Significant

Related by string. Demonstrate Significant * demon strate . DEMONSTRATE . DEMONSTRATES . demonstrates : demonstrate Masimo SET . Demonstrates Efficacy . amply demonstrates . amply demonstrate / signifi cant . sig nificant . Signifi cant . significant : statistically significant differences . statistically significant improvement . demonstrated statistically significant * *

Related by context. Frequent words. (Click for all words.) 82 Drug Candidate 82 Completes Enrollment 81 Significantly Reduces 81 FDA Clears 80 Study Demonstrates 79 Presents Positive 79 Reduces Risk 78 Phase III Trial 78 Clinical Trial Results 78 Patients Treated 78 Phase III Clinical Trial 78 Patient Enrollment 77 Receives FDA Clearance 77 Chronic Hepatitis C 77 FDA Accepts 76 Pivotal Phase III 76 Shows Promise 76 Combination Therapy 75 Elderly Patients 75 Low Dose 75 Preclinical Data 75 Initiates Phase 75 Monotherapy 75 Pivotal Phase 74 Increases Risk 74 Announces Initiation 74 Inhibits 74 FDA Approves 74 Generic Version 74 Achieves Milestone 74 Announces Publication 74 Heart Failure Patients 73 Pivotal Trial 73 Prostate Cancer Patients 73 Well Tolerated 73 Awarded Patent 73 Meta Analysis 73 Advanced Prostate Cancer 73 Metastatic Melanoma 73 Provides Guidance 72 Receives Patent 72 Study Confirms 72 FDA Clearance 72 Announces Presentation 72 Metastatic Colorectal Cancer 72 Study Indicates 72 J Am Coll 72 Issues Guidance 72 Introduces Next Generation 72 Reports Positive 71 Protects Against 71 Cholesterol Drug 71 Cardiovascular Events 71 Receives Positive 71 Benign Prostatic Hyperplasia 71 Postmenopausal Women 71 Pulmonary Arterial Hypertension 71 Induces 70 Study Identifies 70 Announces Positive 70 Introduces Enhanced 70 Small Molecule 70 Guides FY# Quick Facts 70 Monoclonal Antibody 70 Q2 Loss Narrows 70 Announces Enhancements 70 Forecast Quick Facts 70 Diabetic Patients 70 RNAi Therapeutics 70 Atopic Dermatitis 70 Regains Compliance 70 Overactive Bladder 70 Announces Successful Completion 70 美 通 社 70 Q3 Loss Narrows 70 Q2 Loss Widens 70 Holds Promise 69 Updates Guidance 69 Lenalidomide 69 Explore Strategic Alternatives 69 Inc Therapeutic Competitors 69 Provide Comprehensive 69 Reduce Risk 69 Drug Resistant 69 Extended Release 69 Completes Tender Offer 69 Positive Opinion 69 Chronic Heart Failure 69 Net Loss Narrows 69 Blood Thinner 69 Increased Risk 69 Announces Issuance 69 Receives CE 69 Secures Additional 69 J Am Acad 69 Provides Updates 69 FDA Warns 69 CHEAP ONLINE PHARMACY LOW 69 Q1 Loss Widens 69 Guidance Quick Facts 69 Am J Clin

Back to home page